Bill Miller Halozyme Therapeutics, Inc. Call Options Transaction History
Miller Value Partners, LLC
- $219 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HALO
# of Institutions
587Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$862 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$628 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$296 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$191 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$180 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.82B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...